Familial hyperkalemia and hypertension: Pathogenetic insights based on lithium clearance

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 3010-3016

  Mayan, Haim ^a   Melnikov, Semyon ^a   Novikov, Ilya ^a   Holtzman, Eliezer J ^a   Farfel, Zvi ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LITHIUM; PROTEIN KINASE WNK4; SODIUM;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HUMAN; HYPERCALCIURIA; HYPERKALEMIA; HYPERTENSION; MALE; PRIORITY JOURNAL;

EID: 68549096015     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2572     Document Type: Article

References (36)

1. Farfel Z, Iaina A, Rosenthal T, Waks U, Shibolet S, Gafni J 1978 Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible cell membrane defect. Arch Intern Med 138:1828-1832
2. Gordon RD, Klemm SA, Tunny TJ, Stowasser M 1995 Gordon's Syndrome: a sodium-volume dependent form of hypertension with a genetic basis. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management, 2nd ed. New York: Raven Press; 2111-2123
3. Wilson F, Disse-Nicodème S, Choate K, Ishikawa K, Nelson-Wiliams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP 2001 Human hypertension caused by mutations in WNK kinases. Science 293:1107-1112
4. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z 2002 Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 87:3248-3254
5. Mayan H, Munter G, Shaharabany M, Mouallem M, Pauzner R, Holtzman EJ, Farfel Z 2004 Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension; description of a large family with the Q565E WNK4 mutation. J Clin Endocrinol Metab 89:4025-4030
6. Achard JM, Warnock DG, Disse-Nicodème S, Fiqet-Kempf B, Corvol P, Fournier A, Jeunemaitre X 2003 Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation. Am J Med 114:495-498
7. Boer WH, Fransen R, Shirley DG, Walter SJ, Boer P, Koomans HA 1995 Evaluation of the lithium clearance method: direct analysis of tubular lithium handling by micropuncture. Kidney Int 47:1023-1030
8. Shalmi M, Jonassen T, Thomsen K, Kibble JD, Bie P, Christensen S 1998 Model explaining the relation between distal nephron Li absorption and urinary Na excretion in rats. Am J Physiol 274:F445-F452
9. Mount DB, Yu ASL 2008 Transport of inorganic solutes: sodium, chloride, potassium, magnesium, calcium, and phosphate. In: Brenner BM, ed. Brenner, Rector's the kidney, 8th ed. Philadelphia: Saunders; 156-213
10. Mayan H, Mouallem M, Shaharabany M, Pauzner R, Farfel Z 2005 Resolution of hypertension during pregnancy in familial hyperkalemia and hypertension with theWNK4 Q565E mutation. Am J Obstet Gynecol 192:598-603
11. Lalioti MD, Zhang J, Volkman HM, Khle KT, Hoffmann KE, Toka HR, Nelson-Williams C, Ellison DH, Flavell R, Booth CJ, Lu Y, Geller DS, Lifton RP 2006 Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 38: 1124-1132
12. Kahle KT, Ring AM, Lifton RP 2008 Molecular physiology of the WNK kinases. Annu Rev Physiol 70:329-355
13. Peng JB, Warnock DG 2007 WNK4-mediated regulation of renal ion transport proteins. Am J Physiol Renal Physiol 293:F961-F973
14. McCormick JA, Yang CL, Ellison DH 2008 WNK kinases and renal sodium transport in health and disease; an integrated view. Hypertension 51:588-596
15. Huang CL, Yang SS, Lin SH 2008 Mechanism of regulation of renal ion transport by WNK kinases. Curr Opin Nephrol Hypertens 17:519-525
16. + transport: study of familial hyperkalemia and hypertension. Eur J Clin Invest 35:410-415
17. Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, Hebert SC, Gamba G, Lifton RP 2003 Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 100:680-684
18. Yang CL, Angell J, Mitchell R, Ellison DH 2003 WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111:1039-1045
19. Jiang Y, Ferguson WB, Peng JB 2007 WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4. Am J Physiol Renal Physiol 292:F545-F554
20. + channel in vitro and in vivo. Proc Natl Acad Sci USA 104:4020-4024
21. + secretion. Nat Genet 35:372-376
22. - flux in extrarenal epithelia. Proc Natl Acad Sci USA 101:2064-2069
23. Yamauchi K, Rai T, Kobayashi K, Sohara E, Suzuki T, Itoh T, Suda S, Hayama A, Sasaki S, Uchida S 2004 Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci USA 101:4690-4694
24. D561A/+) knock in mouse model. Cell Metab 331-344
25. Nordin BE, Need AG, Morris HA, Horowitz M 1993 The nature and significance of the relationship between urinary sodium and urinary calcium in women. J Nutr 123:1615-1622
26. Mukamel MN, Weisman Y, Somech R, Eisenberg Z, Landman J, Shapira I, Spirer Z, Jurgenson 2001 Vitamin D deficiency in orthodox and non-orthodox Jewish mothers in Israel. Isr Med Ass J 3:419-421
27. Deluca HF 2004 Overview of general physiologic features and functions of Vitamin D. Am J Clin Nutr 80(6 Suppl):1689s-1696s
28. Worcester EM, Coe FL, Evan AP, Bersland KJ, Parks JH, Willis LR, Clark DL, Gillen DL 2008 Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone forming patients. Am J Physiol Renal Physiol F1286-F1294
29. Weder AB 1986 Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension. N Engl J Med 314:198-201
30. Burnier M, Biollaz J, Magnin JL, Bidlingmeyer M, Brunner HR 1994 Renal sodium handling in patients with untreated hypertension and white coat hypertension. Hypertension 23:496-502
31. Staessen JA, Kuznetsova T, Zhang H, Maillard M, Bochud M, Hasenkamp S, Westerkamp J, Richart T, Thijs L, Li X, Brand-Herrmann SM, Burnier M, Brand E 2008 Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension 51:1643-1650
32. Klemm SA, Gordon RD, Tunny TJ, Thompson RE 1991 The syndrome of hypertension and hyperkalemia with normal GFR (Gordon's syndrome): is there increased proximal sodium reabsorption? Clin Invest Med 14:551-558
33. Mayan H, Attar-Herzberg D, Shaharabany M, Holtzman EJ, Farfel Z 2008 Increased urinary Na-Cl cotransporter protein in familial hyperkalemia and hypertension. Nephrol Dial Transplant 23:492-496
34. Thomsen K, Shirley DG 2006 A hypothesis linking sodium and lithium reabsorption in the distal nephron. Nephrol Dial Transplant 21:869-880
35. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ 1995 Trends in prevalence, awareness, treatment and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension 26:60-69
36. Reckelhoff JF, Fortepiani LA 2004 Novel mechanisms responsible for post-menopausal hypertension. Hypertension 43:918-923